19.00
Precedente Chiudi:
$20.08
Aprire:
$20.07
Volume 24 ore:
123.02K
Relative Volume:
0.78
Capitalizzazione di mercato:
$271.17M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-4.76%
1M Prestazione:
-1.14%
6M Prestazione:
+6.86%
1 anno Prestazione:
-52.92%
Neurogene Inc Stock (NGNE) Company Profile
Nome
Neurogene Inc
Settore
Industria
Telefono
(877) 237-5020
Indirizzo
535 W 24TH STREET, NEW YORK
Confronta NGNE con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
NGNE
Neurogene Inc
|
19.00 | 265.46M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurogene Inc Stock (NGNE) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-17 | Iniziato | Craig Hallum | Buy |
2025-05-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
2024-06-27 | Iniziato | BMO Capital Markets | Outperform |
2024-06-11 | Iniziato | Robert W. Baird | Outperform |
2024-04-29 | Iniziato | Leerink Partners | Outperform |
2024-03-21 | Iniziato | William Blair | Outperform |
2024-01-08 | Iniziato | H.C. Wainwright | Buy |
2024-01-05 | Iniziato | Stifel | Buy |
2024-01-04 | Iniziato | TD Cowen | Outperform |
Mostra tutto
Neurogene Inc Borsa (NGNE) Ultime notizie
Regression analysis insights on Neurogene Inc. performance2025 Trade Ideas & AI Powered Market Entry Strategies - Newser
Will Neurogene Inc. stock recover after recent dropIPO Watch & Risk Managed Investment Signals - Newser
Using data tools to time your Neurogene Inc. exitMarket Growth Summary & Risk Managed Trade Strategies - Newser
Neurogene Inc. stock chart pattern explainedMarket Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Predicting Neurogene Inc. trend using moving averagesPortfolio Growth Summary & Community Supported Trade Ideas - Newser
Tick level data insight on Neurogene Inc. volatilityJuly 2025 Breakouts & High Conviction Trade Alerts - Newser
Will a bounce in Neurogene Inc. offer an exitJuly 2025 Weekly Recap & Accurate Buy Signal Notifications - Newser
Neurogene Inc. stock trendline breakdownDividend Hike & Accurate Entry/Exit Alerts - Newser
How to escape a deep drawdown in Neurogene Inc.Entry Point & Long-Term Capital Growth Strategies - Newser
Should you hold or exit Neurogene Inc. now2025 Big Picture & Safe Entry Zone Identification - Newser
Neurogene Inc. stock trend forecastQuarterly Risk Review & Free Weekly Chart Analysis and Trade Guides - Newser
Neurogene Inc. stock volume spike explained2025 Top Decliners & Technical Buy Zone Confirmations - Newser
Is Neurogene Inc. forming a bottoming baseInsider Buying & Stock Portfolio Risk Control - Newser
Pattern recognition hints at Neurogene Inc. upside2025 Analyst Calls & Fast Entry High Yield Stock Tips - Newser
neurogene inc. stock trend forecastM&A Rumor & Stock Portfolio Risk Control - Newser
Using Ichimoku Cloud for Neurogene Inc. technicalsMarket Risk Summary & Capital Efficient Trading Techniques - Newser
How to build a custom watchlist for Neurogene Inc.Trend Reversal & Fast Exit/Entry Strategy Plans - Newser
Nuveen LLC Purchases Shares of 27,482 Neurogene Inc. $NGNE - MarketBeat
regression analysis insights on neurogene inc. performance2025 Top Decliners & Expert Approved Trade Ideas - Newser
Will Neurogene Inc. rebound enough to break evenMarket Movement Recap & Pattern Based Trade Signal System - Newser
News impact scoring models applied to Neurogene Inc.July 2025 Fed Impact & Stepwise Trade Signal Guides - Newser
Applying Elliott Wave Theory to Neurogene Inc.July 2025 Movers & Safe Entry Point Identification - Newser
What technical models suggest about Neurogene Inc.’s comeback2025 Market Trends & Weekly Market Pulse Updates - Newser
will neurogene inc. rebound enough to break even2025 Biggest Moves & AI Powered Buy/Sell Recommendations - Newser
using data tools to time your neurogene inc. exitQuarterly Market Review & High Return Trade Opportunity Guides - Newser
Has Neurogene Inc. found a price floor2025 Volume Leaders & Expert Curated Trade Ideas - Newser
How moving averages guide Neurogene Inc. tradingForecast Cut & Free Weekly Chart Analysis and Trade Guides - Newser
How sentiment analysis helps forecast Neurogene Inc.July 2025 Selloffs & Verified Trade Idea Suggestions - Newser
What earnings revisions data tells us about Neurogene Inc.July 2025 Trade Ideas & Safe Capital Growth Plans - Newser
Are Bears Losing Grip on Neurogene Inc.Portfolio Return Report & Smart Allocation Stock Reports - beatles.ru
Neurogene Inc Azioni (NGNE) Dati Finanziari
Non sono disponibili dati finanziari per Neurogene Inc (NGNE). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):